Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Placing

10 Aug 2009 07:00

RNS Number : 1293X
Imaginatik PLC
10 August 2009
 



10 August 2009

Imaginatik plc

("Imaginatik" or the "Company")

Placing to raise approximately £1.576 million

Imaginatik plc (AIM: IMTK), a leading provider of enterprise collaborative software and processes, announces that it has conditionally raised approximately £1.576 million through a placing of 26,266,666 new ordinary shares of 0.0625p each (the "Placing Shares") at a price of pence per share (the "Placing"). The Company intends that the net proceeds of the Placing will be used to provide the Company with the resources to pursue its growth plans and for general working capital purposes.

The Placing Shares have been conditionally placed by Arbuthnot Securities Limited ("Arbuthnot") with institutional and other investors. Application will be made to London Stock Exchange plc for the Placing Shares to be admitted to trading on AIM. Subject, inter alia, to admission of the Placing Shares to AIM becoming effective, dealings in the Placing Shares are expected to commence on AIM at 8.00 a.m. on 13 August 2009. The Placing Shares represent approximately 20 per cent. of the Company's existing issued share capital and will, when issued, represent approximately 16.5 per cent. of the Company's enlarged share capital. Following Admission, the Company will have 159,186,376 Ordinary Shares in issue.

Pursuant to the terms of the placing agreement, Arbuthnot, as agent for Imaginatik, has agreed to use its reasonable endeavours to place the Placing Shares with investors procured by it. The Placing is not underwritten. The Placing Price of 6 pence per Placing Share represents a discount of approximately 4 per cent. to the closing mid-market price of 6.25 pence per ordinary share on 7 August 2009, being the last dealing day prior to the date of this announcement.

The issue of the Placing Shares is conditional, amongst other things, on:

(i) admission to trading on AIM of the Placing Shares; and

(ii) the Placing Agreement not being terminated prior to Admission.

The Placing Agreement contains warranties given by the Company with respect to its business and certain matters connected with the Placing. In addition, the Company has given certain indemnities to Arbuthnot in connection with the Placing and Arbuthnot's performance of services in relation to the Placing.

Mark Turrell, CEO of Imaginatik, commented, "We are delighted to have secured this additional funding from new and existing investors. With the Placing oversubscribed, this is a very strong endorsement of the potential of Imaginatik, leaving us well positioned to pursue our growth strategy. Our pipeline continues to grow, which combined with our strong levels of recurring revenue, gives us confidence in our ability to capitalise on our market leading position." 

For further information, please contact:

Imaginatik plc
020 7917 2975
Mark Turrell, CEO
 
Shawn Taylor, CFO
 
 
 
Arbuthnot Securities Limited
020 7012 2000 
Tom Griffiths/Richard Johnson/
Niamh Corbett
 
 
 
ICIS
020 7651 8688
Caroline Evans-Jones/ Hilary Millar
 

About Imaginatik

Imaginatik is a leading provider of web-based enterprise collaboration software. Imaginatik's core software, Idea Central, is designed to help companies focus on idea generation towards strategic business objectives, and to share, develop and review those ideas across the organisation. Some of the world's largest organisations such as Merck, Dow, Chevron, General Electric and Cargill use Imaginatik's software, consulting and leading-edge research to enable their best-of-breed innovation, cost-reduction and process improvement activities.

Having been named as a World Economic Forum Technology Pioneer and a finalist for the IBM Lotus Awards in the Best Industry Solution category, Imaginatik's software and consulting services have helped clients discover significant sources of additional revenue, as well as tangible cost savings. Imaginatik is also committed to developing strategic solutions in the field of innovation, working with academic institutions such as the Hult Business School in Boston, and the Cass School of Business, London, as well as leading practitioners of corporate innovation.

For further information please visit http://www.imaginatik.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUBVWRKNRWRAR
Date   Source Headline
27th Sep 20187:30 amRNSSuspension - Imaginatik plc
26th Sep 20187:00 amRNSUpdate on potential equity investment
17th Sep 20187:00 amRNSUpdate on potential equity investment
11th Sep 201811:35 amRNSUpdate regarding Nominated Adviser
11th Sep 20187:00 amRNSFinal Results
4th Sep 20187:00 amRNSUpdate on potential equity investment
29th Aug 20189:22 amRNSHolding(s) in Company
28th Aug 20189:12 amRNSHolding(s) in Company
24th Aug 20183:39 pmRNSHolding(s) in Company
17th Aug 20183:40 pmRNSIssue of Equity
26th Jul 20187:00 amRNSNew Finance Agreement
25th Jul 20181:05 pmRNSStmnt re Share Price Movement
10th Jul 20184:56 pmRNSHolding(s) in Company
10th Jul 20189:48 amRNSHolding(s) in Company
10th Jul 20187:00 amRNSAppointment of CEO
3rd Jul 20185:45 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSIssue of Equity
29th Jun 201810:46 amRNSResult of General Meeting and Total Voting Rights
22nd Jun 20187:00 amRNSContract Win
18th Jun 201812:59 pmRNSHolding(s) in Company
15th Jun 20187:00 amRNSRelease of mobile update to Innovation Central
14th Jun 20187:00 amRNSPosting of circular and notice of general meeting
5th Jun 20185:40 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSResult of strategic review and new funding
29th May 20187:00 amRNSUpdate on sales process and funding
1st May 20187:00 amRNSTrading Statement
21st Mar 20187:00 amRNSUpdate on strategic review and formal sale process
14th Feb 201812:38 pmRNSForm 8.3 - [Imaginatik plc]
12th Feb 20185:51 pmRNSForm 8.3 - Imaginatik plc
9th Feb 20185:50 pmRNSForm 8.3 - Imaginatik
9th Feb 20185:48 pmRNSForm 8.3 - Imaginatik
8th Feb 20183:36 pmRNSHolding(s) in Company
1st Feb 20183:04 pmRNSForm 8 (DD) - Imaginatik plc
1st Feb 201811:36 amRNSForm 8.3 - Imaginatik PLC
1st Feb 20187:00 amRNSForm 8 (OPD) - Imaginatik plc
1st Feb 20187:00 amRNSStrategic review including formal sale process
7th Dec 20177:00 amRNSHalf-year Report
29th Sep 20177:00 amRNSGrant of Options
27th Sep 20177:00 amRNSContract Win
20th Sep 20179:37 amRNSHolding(s) in Company
7th Sep 20175:50 pmRNSResult of AGM
15th Aug 20178:00 amRNSNotice of AGM
7th Aug 20177:00 amRNSFinal Results
10th Jul 201710:47 amRNSHolding(s) in Company
5th Jul 20174:32 pmRNSHolding(s) in Company
4th Jul 20179:51 amRNSHolding(s) in Company
4th Jul 20177:00 amRNSHolding(s) in Company
3rd Jul 201711:10 amRNSResult of Open Offer and Total Voting Rights
27th Jun 20177:00 amRNSResult of GM and Total Voting Rights
9th Jun 20171:04 pmRNSPlacing and Open Offer to raise up to £1.9 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.